T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report published on Wednesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

NASDAQ TTOO opened at $0.22 on Wednesday. T2 Biosystems has a one year low of $0.21 and a one year high of $6.95. The business has a fifty day moving average price of $0.38 and a 200 day moving average price of $1.82.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.